Cellectis (CLLS) Other Operating Expenses (2015 - 2026)

Cellectis' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $63000.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 85.21% year-over-year to $63000.0; the TTM figure through Mar 2026 stood at $275000.0 (down 77.82% YoY), while the FY2025 annual figure was $849000.0, changed 0.0% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $63000.0, up from -$320000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $839000.0 in Q4 2022, with the low at -$1.2 million in Q4 2023.
• The 5-year median for Other Operating Expenses is $63000.0 (2026), against an average of $102294.1.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses soared 11885.71% in 2022, then sank 3009.52% in 2023.
• Cellectis' Other Operating Expenses stood at $839000.0 in 2022, then tumbled by 243.5% to -$1.2 million in 2023, then jumped by 96.1% to -$47000.0 in 2024, then slumped by 580.85% to -$320000.0 in 2025, then surged by 119.69% to $63000.0 in 2026.
• Business Quant data shows CLLS's Other Operating Expenses at $63000.0 in Q1 2026, -$320000.0 in Q4 2025, and $154000.0 in Q3 2025.